Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Jaguar Health, Inc.

< Previous 1 2 3 Next >
News headline image
Jaguar Health Reports Second Quarter 2026 Financials
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
From Jaguar Health, Inc.
Via ACCESS Newswire
Tickers JAGX
News headline image
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health to Participate in BIO International Convention (BIO 2022)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
From Jaguar Health, Inc.
Via AccessWire
Topics Economy
Tickers JAGX
News headline image
Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Launch of Mytesi Telehealth Program
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.